Co-op moves back into pharmaceuticals market

LinkedIn +

The Co-op is moving back into the healthcare market with the acquisition of Dimec, a healthcare technology start-up, which has developed a digital solution for repeat prescriptions.

The co-founders of Dimec will work with the Co-op team, and a number of new jobs will be created in digital, operational and clinical roles. These will be located in Manchester and the Co-op’s distribution centre at Lea Green in Merseyside.

The Co-op sold its previous pharmacy business to Bestway in 2014.

This acquisition will enable The Co-op to compete in the £10.5 billion pharmacy market, where over 1.1 billion prescriptions are written annually in England. Some 29 million people in the UK receive a regular repeat prescription and this number is forecast to grow significantly in the years ahead.

Tim Davies, director of Co-op Ventures, said: “The acquisition of Dimec allows us to accelerate the development of our healthcare proposition, and provides the technology required to ensure customers can interact with their NHS GP more conveniently.”

Share this story: